1. Home
  2. TOVX vs HUIZ Comparison

TOVX vs HUIZ Comparison

Compare TOVX & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TOVX

Theriva Biologics Inc.

N/A

Current Price

$0.25

Market Cap

14.7M

Sector

Health Care

ML Signal

N/A

Logo Huize Holding Limited

HUIZ

Huize Holding Limited

N/A

Current Price

$1.37

Market Cap

16.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TOVX
HUIZ
Founded
2001
2006
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
14.7M
16.8M
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
TOVX
HUIZ
Price
$0.25
$1.37
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$1.00
$2.30
AVG Volume (30 Days)
1.3M
10.9K
Earning Date
05-13-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
89.07
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$8.58
Revenue Next Year
N/A
$6.64
P/E Ratio
N/A
$7.81
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$1.19
52 Week High
$0.86
$4.16

Technical Indicators

Market Signals
Indicator
TOVX
HUIZ
Relative Strength Index (RSI) 64.63 39.33
Support Level $0.18 $1.19
Resistance Level $0.49 $1.55
Average True Range (ATR) 0.03 0.09
MACD 0.00 -0.01
Stochastic Oscillator 87.77 11.90

Price Performance

Historical Comparison
TOVX
HUIZ

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.

Share on Social Networks: